Usually, hepatitis B triple yang can be treated to normalize liver function and reduce infectiousness, but the possibility of completely removing the virus to achieve a cure is low, and if chronic hepatitis B develops into cirrhosis or liver cancer, it cannot be cured. Patients should actively cooperate with doctors to take treatment measures. Hepatitis B triple positive is found through Hepatitis B five tests that Hepatitis B surface antigen, Hepatitis B e antigen and Hepatitis B core antibody are positive, which indicates that the virus in the patient’s body is actively replicating and highly infectious. Through antiviral treatment and hepatoprotective treatment, patients’ liver function can often be normalized, and it is possible that the big triple positive can be transformed into small triple positive, that is, the speed of viral replication and the infectiousness will be reduced, but the possibility of a complete cure is small. If the condition of some patients is mild and their liver function is normal and there is no histologic damage to the liver, treatment may not be necessary. However, for those with abnormal liver function or liver damage, antiviral treatment is required, and commonly used drugs include entecavir and tenofovir; some patients can also be treated with choleretic and hepatoprotective drugs such as ursodeoxycholic acid and reduced glutathione. It is recommended that those who are diagnosed with hepatitis B teratitis III actively follow the doctor’s instructions for treatment, and do not use drugs or prescriptions indiscriminately.